Maravai Lifesciences Holdings (MRVI) Amortization of Goodwill (2024 - 2025)
Maravai Lifesciences Holdings (MRVI) recorded quarterly Amortization of Goodwill of $30.4 million in Q2 2025, down 80.29% quarter-over-quarter from $154.2 million in Q3 2024.
Maravai Lifesciences Holdings (MRVI) Amortization of Goodwill (2024 - 2025) Analysis & Trends
Maravai Lifesciences Holdings' Amortization of Goodwill history runs 2 years deep, the most recent figure standing at $30.4 million for Q2 2025.
- In Q2 2025, Amortization of Goodwill changed N/A year-over-year to $30.4 million; the TTM figure through Sep 2025 stood at $30.4 million (down 80.29% YoY), while the FY2024 annual figure was $166.2 million, changed N/A from the prior year.
- Amortization of Goodwill was $30.4 million for Q2 2025 at Maravai Lifesciences Holdings, down from $154.2 million in the prior quarter.
- In the past five years, Amortization of Goodwill ranged from a high of $154.2 million in Q3 2024 to a low of $30.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Maravai Lifesciences Holdings | 747.50 Mn | 739.10 Mn | 33.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 30.40 Mn |
| Jun 30, 2025 | 30.40 Mn |
| Sep 30, 2024 | 154.24 Mn |
| Sep 30, 2024 | 154.24 Mn |